An internal promotion, Meriweather is primarily responsible for developing and maintaining the enterprise sales strategy, gaining sales from strategic retail customers, and developing executive relationships with group purchasing organizations.
“Rob will be a great addition to the leadership team at H. D. Smith,” said Scott Wilson, senior vice president drug divisions. “His vast experience in sales on the local, regional and national level will be an asset to leading our sales force.”
An H. D. Smith associate since 2012, Meriweather most recently worked with the organization’s customers as director of retail national accounts, growing this segment by more than 30 percent during his tenure. In that role, he reported directly to Wilson, with responsibility for targeting, maintaining and growing the organization’s largest market opportunities by creating unique sales strategies and value propositions for large regional and national chain pharmacies.
Previous to H. D. Smith, Meriweather served as vice president of global sales for HemCon Medical Technologies, Inc., and was responsible for domestic sales growth and international sales expansion of the product line. Prior to that, he served as a national account manager for Cardinal Health, managing more than $450 million in drug distribution business with regional grocery chains.
Meriweather earned a bachelor’s degree in business administration from Otterbein University. He lives in Columbus, Ohio.
About H. D. Smith
H. D. Smith is the largest, privately held national wholesaler, with a complete line of healthcare products and solutions to improve patient care. The company creates value and an extraordinary customer experience by impacting the healthcare supply chain. Bridging the gap between manufacturer and patient, H. D. Smith’s specialty solutions division offers a unique suite of strategic programs for patient access on behalf of pharmaceutical suppliers. Headquartered in Springfield, Illinois, H. D. Smith also operates CompleteCare Pharmacy, Smith Medical Partners, Triplefin and Valley Wholesale Drug.